MeSH Review:
Toxoplasmosis
Baden,
Katz,
Franck,
Tsang,
Hall,
Rubin,
Jarcho,
Derouich-Guergour,
Aldebert,
Vigan,
Jouvin-Marche,
Marche,
Aubert,
Ambroise-Thomas,
Pelloux,
- Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. Girard, P.M., Landman, R., Gaudebout, C., Olivares, R., Saimot, A.G., Jelazko, P., Gaudebout, C., Certain, A., Boué, F., Bouvet, E. N. Engl. J. Med. (1993)
- Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study. Heald, A., Flepp, M., Chave, J.P., Malinverni, R., Rüttimann, S., Gabriel, V., Renold, C., Sugar, A., Hirschel, B. Ann. Intern. Med. (1991)
- Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells. Yang, T.H., Aosai, F., Norose, K., Ueda, M., Yano, A. J. Immunol. (1995)
- AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. d'Arminio Monforte, A., Vago, L., Lazzarin, A., Boldorini, R., Bini, T., Guzzetti, S., Antinori, S., Moroni, M., Costanzi, G. AIDS (1992)
- Toxoplasmosis presenting as panhypopituitarism in a patient with the acquired immune deficiency syndrome. Milligan, S.A., Katz, M.S., Craven, P.C., Strandberg, D.A., Russell, I.J., Becker, R.A. Am. J. Med. (1984)
- Acquired immunodeficiency syndrome: cerebral computed tomographic manifestations. Whelan, M.A., Kricheff, I.I., Handler, M., Ho, V., Crystal, K., Gopinathan, G., Laubenstein, L. Radiology. (1983)
- Synergistic role of micronemal proteins in Toxoplasma gondii virulence. Cérède, O., Dubremetz, J.F., Soête, M., Deslée, D., Vial, H., Bout, D., Lebrun, M. J. Exp. Med. (2005)
- Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program. Kovacs, J.A. Lancet (1992)
- Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Podzamczer, D., Salazar, A., Jiménez, J., Consiglio, E., Santín, M., Casanova, A., Rufí, G., Gudiol, F. Ann. Intern. Med. (1995)
- NIH conference. Recent advances in the management of AIDS-related opportunistic infections. Lane, H.C., Laughon, B.E., Falloon, J., Kovacs, J.A., Davey, R.T., Polis, M.A., Masur, H. Ann. Intern. Med. (1994)
- Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers. Wong, B., Gold, J.W., Brown, A.E., Lange, M., Fried, R., Grieco, M., Mildvan, D., Giron, J., Tapper, M.L., Lerner, C.W. Ann. Intern. Med. (1984)
- Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Cesbron-Delauw, M.F., Guy, B., Torpier, G., Pierce, R.J., Lenzen, G., Cesbron, J.Y., Charif, H., Lepage, P., Darcy, F., Lecocq, J.P. Proc. Natl. Acad. Sci. U.S.A. (1989)
- Tumor necrosis factor-independent protective effect of recombinant IFN-gamma against acute toxoplasmosis in T cell-deficient mice. Suzuki, Y., Joh, K., Kobayashi, A. J. Immunol. (1991)
- Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Torres, R.A., Barr, M., Thorn, M., Gregory, G., Kiely, S., Chanin, E., Carlo, C., Martin, M., Thornton, J. Am. J. Med. (1993)
- Letter: Sulfisoxazole called suboptimal therapy in toxoplasmosis. Frenkel, J.K. Neurology (1975)
- Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin 2 production and macrophage-mediated inhibitory effects. Haque, S., Khan, I., Haque, A., Kasper, L. Infect. Immun. (1994)
- Recurrent congenital toxoplasmosis in a woman with lupus erythematosus. D'Ercole, C., Boubli, L., Franck, J., Casta, M., Harle, J.R., Chagnon, C., Cravello, L., Leclaire, M., Blanc, B. Prenat. Diagn. (1995)
- Neuropathology and host-parasite relationship of acute experimental toxoplasmosis of the blue fox (Alopex lagopus). Bjerkås, I. Vet. Pathol. (1990)
- The clastogenic effect of pyrimethamine (Daraprim) on human chromosomes in lymphocyte cultures. Egeli, U., Erdogan, G. Cell Biol. Toxicol. (1991)
- Application of the polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients. Roth, A., Roth, B., Höffken, G., Steuber, S., Khalifa, K.I., Janitschke, K. Eur. J. Clin. Microbiol. Infect. Dis. (1992)
- A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii. Villegas, E.N., Lieberman, L.A., Mason, N., Blass, S.L., Zediak, V.P., Peach, R., Horan, T., Yoshinaga, S., Hunter, C.A. J. Immunol. (2002)
- Polymerase chain reaction on sputum for the diagnosis of pulmonary toxoplasmosis in AIDS patients. Abraham, B., Tamby, I., Reynes, J., Bastien, P. AIDS (2000)
- Coinfection with Toxoplasma gondii inhibits antigen-specific Th2 immune responses, tissue inflammation, and parasitism in BALB/c mice infected with Leishmania major. Santiago, H.C., Oliveira, M.A., Bambirra, E.A., Faria, A.M., Afonso, L.C., Vieira, L.Q., Gazzinelli, R.T. Infect. Immun. (1999)
- Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. Foot, A.B., Garin, Y.J., Ribaud, P., Devergie, A., Derouin, F., Gluckman, E. Bone Marrow Transplant. (1994)
- Toxoplasma gondii. Zygmunt, D.J. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. (1990)
- Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. Deckert-Schlüter, M., Bluethmann, H., Rang, A., Hof, H., Schlüter, D. J. Immunol. (1998)
- IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. Lieberman, L.A., Cardillo, F., Owyang, A.M., Rennick, D.M., Cua, D.J., Kastelein, R.A., Hunter, C.A. J. Immunol. (2004)
- Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. Yap, G.S., Scharton-Kersten, T., Charest, H., Sher, A. J. Immunol. (1998)
- Chemokine secretion of human cells in response to Toxoplasma gondii infection. Denney, C.F., Eckmann, L., Reed, S.L. Infect. Immun. (1999)
- Toxoplasma gondii infection can regulate the expression of tumour necrosis factor-alpha receptors on human cells in vitro. Derouich-Guergour, D., Aldebert, D., Vigan, I., Jouvin-Marche, E., Marche, P.N., Aubert, D., Ambroise-Thomas, P., Pelloux, H. Parasite Immunol. (2002)
- Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole. Baden, L.R., Katz, J.T., Franck, L., Tsang, S., Hall, M., Rubin, R.H., Jarcho, J. Transplantation (2003)
- Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Saeij, J.P., Boyle, J.P., Grigg, M.E., Arrizabalaga, G., Boothroyd, J.C. Infect. Immun. (2005)
- Isocratic reversed-phase HPLC method to measure pyrimethamine extracted from plasma of infants treated for toxoplasmosis. Zytkovicz, T.H., Salter, J., Hennigan, L., Timperi, R., Maguire, J., Hoff, R. Clin. Chem. (1991)
- Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. Derouin, F., Caroff, B., Chau, F., Prokocimer, P., Pocidalo, J.J. Antimicrob. Agents Chemother. (1992)
- Hyperperfusion and early technetium-99m-HMPAO SPECT appearance of central nervous system toxoplasmosis. Catafau, A.M., Solá, M., Lomeña, F.J., Guelar, A., Miró, J.M., Setoain, J. J. Nucl. Med. (1994)